Bio-Path Holdings, Inc.
P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION
Last updated:
Abstract:
Provided herein are improved delivery systems for oligonucleotides, said delivery system comprising a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide, which targets a STAT3-encoding polynucleotide. Methods of treating patients with said delivery systems are also provided.
Status:
Application
Type:
Utility
Filling date:
4 Jun 2021
Issue date:
28 Apr 2022